GGrantIndex
← Leaderboards

Ronald G Strauss

University Of Iowa

$2,442,597
Attributed
$2,442,597
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $310K · FY200512
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$8,298,938 · 10

By mechanism

P01$6,226,018 · 2
U01$2,032,014 · 1
M01$40,906 · 7

Top collaborators

No co-investigators on record.

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchAnemiaHuman SubjectBlood TransfusionClinical TrialsPremature Infant HumanAutotransfusionCord BloodPatient Oriented ResearchResourcesMonoclonal AntibodyAutoantibodyThrombocytopeniaBlood VolumeHematopoietic Stem CellsErythropoiesisHemostatic FunctionInstitutionTransfusionBlood Disorder ChemotherapyBlood CoagulationClinical Trials NetworkBlood ChemistryBlood

Grant awards (26)

Transfusion Medicine/Hemostasis Clinical Research Network$164,063
U01 · FY2012 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Network$187,500
U01 · FY2009 · HL · contact PI
Transfusion Medicine/Hemostasis Clinical Research Network$187,500
U01 · FY2007 · HL · contact PI
PROPHYLACTIC PLATELET DOSE STRATEGY TO PREVENT BLEEDING IN THROMBOCYTOPENIA$303
M01 · FY2007 · RR · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$292,951
U01 · FY2006 · HL · contact PI
PROPHYLACTIC PLATELET DOSE STRATEGY TO PREVENT BLEEDING IN THROMBOCYTOPENIA$496
M01 · FY2006 · RR · contact PI
Transfusion Medicine/Hemostasis Core Clinical Center$300,000
U01 · FY2005 · HL
CLINICAL AND IMMUNO-HEMATOLOGIC EFFECTS OF PLACENTAL BLOOD$9,064
M01 · FY2005 · RR
PROPHYLACTIC PLATELET DOSE STRATEGY TO PREVENT BLEEDING IN THROMBOCYTOPENIA$971
M01 · FY2005 · RR
Transfusion Medicine/Hemostasis Core Clinical Center$300,000
U01 · FY2004 · HL
Clinical and Immuno-Hematologic Effects of Placental Blood$30,072
M01 · FY2004 · RR
NEONATAL ANEMIA--PATHOPHYSIOLOGY AND TREATMENT$1,478,120
P01 · FY2003 · HL
Transfusion Medicine/Hemostasis Core Clinical Center$300,000
U01 · FY2003 · HL
NEONATAL ANEMIA--PATHOPHYSIOLOGY AND TREATMENT$1,444,108
P01 · FY2002 · HL
Transfusion Medicine/Hemostasis Core Clinical Center$300,000
U01 · FY2002 · HL
CORE--STATISTICAL AND RESEARCH SUPPORT$0
P01 · FY2002 · HL
CLINICAL &IMMUNO-HEMATOLOGIC EFFECTS OF PLACENTAL BLOOD$0
M01 · FY2002 · RR
ACTIVATION OF CLOTTING BY VIA LVM BLOOD GAS &CHEMISTRY MONITOR$0
M01 · FY2002 · RR
NEONATAL ANEMIA--PATHOPHYSIOLOGY AND TREATMENT$1,484,307
P01 · FY2001 · HL
CORE--STATISTICAL AND RESEARCH SUPPORT$0
P01 · FY2001 · HL
ACTIVATION OF CLOTTING BY VIA LVM BLOOD GAS &CHEMISTRY MONITOR$0
M01 · FY2001 · RR
CLINICAL &IMMUNO-HEMATOLOGIC EFFECTS OF PLACENTAL BLOOD$0
M01 · FY2001 · RR
NEONATAL ANEMIA--PATHOPHYSIOLOGY AND TREATMENT$1,449,806
P01 · FY2000 · HL
CORE--STATISTICAL AND RESEARCH SUPPORT$369,677
P01 · FY2000 · HL
ACTIVATION OF CLOTTING BY VIA LVM BLOOD GAS &CHEMISTRY MONITOR$0
M01 · FY2000 · RR
CLINICAL &IMMUNO-HEMATOLOGIC EFFECTS OF PLACENTAL BLOOD$0
M01 · FY2000 · RR